VITRAKVI 25 mg, gélule

ReimbursedATC L01EX12

Last synced from Base de données publique des médicaments — BDPM (France) on June 3, 2026

Identification

ManufacturerBAYER AG (ALLEMAGNE)

CountryFR (France)

ATC codeL01EX12

Dispensing—

ReimbursedYes

SourceBase de données publique des médicaments — BDPM (France)

Last synced6/3/2026

Packs · 1

cip13
3400930187999
1 flacon(s) polyÃ©thylÃ¨ne haute densitÃ© (PEHD) avec fermeture de sÃ©curitÃ© enfant de 56 gÃ©lule(s)
EUR 4.06

Annotations

No annotations yet.

Raw payload (JSON)

{
  "cis": "67022406",
  "date_amm": "2019-09-19",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/19/1385",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "gélule",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Oui"
}

Related drugs

Other records sharing ATC code L01EX12.

Access this data programmatically

Query VITRAKVI 25 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs